US Stocks
/
Glaukos Corporation Share Price

Glaukos Corporation Share Price

NYSE: GKOS | Mid Cap
$165.63
+$4.73 (2.94%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Glaukos Corporation Stock Performance

Open
$161.17
Prev. Close
$160.90
Circuit Range
N/A
Day Range
$160.25 - $166.93
Year Range
$73.74 - $191.30
Volume
1,13,398
Average Traded
$164.39

Glaukos Corporation Share Price Today

As of 10 October 2026, Glaukos Corporation's share price is $165.63. The stock opened at $161.17, compared to its previous close of $160.90. During today's trading session, Glaukos Corporation's share price traded between $160.25 and $166.93, with an average price of $163.59. Over the past 52 weeks, the stock has recorded a high of $191.30 and a low of $73.74. In terms of performance, Glaukos Corporation's share price has risen by 14.98% over the last six months and is up 88.13% on a year-on-year basis.

Glaukos Corporation Share Price Chart

$160.25$166.93
L
Show Current Price
H

Glaukos Corporation Stock Fundamentals & Key Indicators

Market Cap
$9.47B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.19
Revenue (TTM)
$507.44B
Return On Equity (TTM)
-27.55%
Profit Margin
-36.99%
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-13.25%

Glaukos Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$133.54$143.12$150.57$185.61
Net Profit-$16.23-$133.66-$19.78-$18.38
Net Profit Margin-12.15%-93.39%-13.14%-9.90%
Income ChangeN/A-723.54%85.20%7.08%

Glaukos Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$282.86$314.71$383.48$507.44
Net Profit-$99.20-$134.66-$146.37-$187.69
Net Profit Margin-35.07%-42.79%-38.17%-36.99%
Income ChangeN/A-35.75%-8.70%-28.23%

About Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Corporation Historical Returns

MonthOpenCloseChange %
Oct 2026
$162.25
$165.40
+0.71%
Sep 2026
$178.15
$164.24
-9.54%
Aug 2026
$169.56
$181.56
+8.80%
Jul 2026
$140.18
$166.87
+19.48%
Jun 2026
$102.76
$139.66
+35.19%
May 2026
$144.00
$103.31
-28.28%
Apr 2026
$109.00
$144.05
+33.67%
Mar 2026
$119.00
$107.77
-10.46%
Feb 2026
$119.81
$120.36
+0.78%
Jan 2026
$113.28
$119.43
+5.82%
Dec 2025
$105.67
$112.86
+6.18%
Nov 2025
$87.42
$106.29
+20.73%

GKOS Share Price FAQs

What is Glaukos Corporation share price today?

chevron-up
Glaukos Corporation share price today is $165.63 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Glaukos Corporation stock?

chevron-up
The 52 week high of Glaukos Corporation stock is $191.30, while the 52 week low is $73.74 as of 10 Oct '26.

What is GKOS's market capitalisation today?

chevron-up
GKOS market capitalisation is $9.47B as of October 10, 2026, at 4:41 am IST.

What is GKOS's net income for the last quarter?

chevron-up
GKOS's net income for the last quarter is -18.38B USD.

What is the 5 year returns of GKOS?

chevron-up
The 5 year returns of GKOS is 262.35% as on 10 Oct '26.

What is the high & low stock price of GKOS today?

chevron-up
GKOS stock price hit a high of $166.93 and low of $160.25 as of 10 Oct '26.

Can I buy GKOS shares in India?

chevron-up
Yes. You can buy GKOS in India by opening an international trading account.